Shalby Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
269.10 -0.85 (-0.31%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
263.05
Today’s High
276
52 Week Low
134.8
52 Week High
333.85
270.95 +0.90 (0.33%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
267.15
Today’s High
276.75
52 Week Low
135
52 Week High
339.5
Key Metrics
- Market Cap (In Cr) 2894.73
- Beta 1.69
- Div. Yield (%) 0.44
- P/B 3.12
- TTM P/E 39.87
- Peg Ratio 0.91
- Sector P/E 29.44
- D/E -
- Open Price 263.05
- Prev Close 269.95
Shalby Analysis
Price Analysis
-
1 Week-0.74%
-
3 Months-11.15%
-
6 Month-5.77%
-
YTD-10.76%
-
1 Year95.55%
Risk Meter
- 39% Low risk
- 39% Moderate risk
- 39% Balanced Risk
- 39% High risk
- 39% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 2
- 2
- 2
- 2
Shalby News
Stocks to Watch: Honasa Consumer, Welspun Corp, InterGlobe Aviation, TVS Motor
1 min read . 23 Nov 2023Shalby: This small-cap stock rallied 124% in just six months, up 218% in 3 years
1 min read . 22 Nov 2023Ashok Leyland, SRF, Godrej Consumer among 12 technical picks to buy this week
7 min read . 06 Nov 2023Q2 results preview: Hospitals to be driven by higher occupancy, rising revenue
2 min read . 19 Oct 2023Shalby Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2023
- Total Revenue
- 804.92
- Selling/ General/ Admin Expenses Total
- 228.05
- Depreciation/ Amortization
- 48.09
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 712.32
- Operating Income
- 92.6
- Net Income Before Taxes
- 102.04
- Net Income
- 67.7
- Diluted Normalized EPS
- 6.31
- Period
- 2023
- Total Assets
- 1281.36
- Total Liabilities
- 353.68
- Total Equity
- 927.69
- Tangible Book Valueper Share Common Eq
- 84.44
- Period
- 2023
- Cashfrom Operating Activities
- 67.79
- Cashfrom Investing Activities
- -61.08
- Cashfrom Financing Activities
- -50.02
- Net Changein Cash
- -43.31
- Period
- 2022
- Total Revenue
- 698.94
- Selling/ General/ Admin Expenses Total
- 345.71
- Depreciation/ Amortization
- 42.87
- Other Operating Expenses Total
- 190.08
- Total Operating Expense
- 625.2
- Operating Income
- 73.75
- Net Income Before Taxes
- 79.15
- Net Income
- 54.12
- Diluted Normalized EPS
- 5.32
- Period
- 2022
- Total Assets
- 1193.54
- Total Liabilities
- 317.22
- Total Equity
- 876.32
- Tangible Book Valueper Share Common Eq
- 79.19
- Period
- 2022
- Cashfrom Operating Activities
- 18.92
- Cashfrom Investing Activities
- -60.28
- Cashfrom Financing Activities
- 90.46
- Net Changein Cash
- 49.1
- Period
- 2021
- Total Revenue
- 430.9
- Selling/ General/ Admin Expenses Total
- 190.58
- Depreciation/ Amortization
- 36.8
- Other Operating Expenses Total
- 46.55
- Total Operating Expense
- 377.64
- Operating Income
- 53.26
- Net Income Before Taxes
- 55.05
- Net Income
- 42.4
- Diluted Normalized EPS
- 4.14
- Period
- 2021
- Total Assets
- 996.62
- Total Liabilities
- 161.97
- Total Equity
- 834.65
- Tangible Book Valueper Share Common Eq
- 75.69
- Period
- 2021
- Cashfrom Operating Activities
- 79.15
- Cashfrom Investing Activities
- -51.27
- Cashfrom Financing Activities
- -29.86
- Net Changein Cash
- -1.98
- Period
- 2020
- Total Revenue
- 486.85
- Selling/ General/ Admin Expenses Total
- 232.9
- Depreciation/ Amortization
- 36.02
- Other Operating Expenses Total
- 46.47
- Total Operating Expense
- 440.39
- Operating Income
- 46.46
- Net Income Before Taxes
- 56.73
- Net Income
- 27.59
- Diluted Normalized EPS
- 2.56
- Period
- 2020
- Total Assets
- 966.63
- Total Liabilities
- 167.46
- Total Equity
- 799.17
- Tangible Book Valueper Share Common Eq
- 72.67
- Period
- 2020
- Cashfrom Operating Activities
- 55.37
- Cashfrom Investing Activities
- -30.67
- Cashfrom Financing Activities
- -21.5
- Net Changein Cash
- 3.21
- Period
- 2019
- Total Revenue
- 462.26
- Selling/ General/ Admin Expenses Total
- 219.39
- Depreciation/ Amortization
- 33.17
- Other Operating Expenses Total
- 47.58
- Total Operating Expense
- 412.45
- Operating Income
- 49.81
- Net Income Before Taxes
- 50.39
- Net Income
- 31.66
- Diluted Normalized EPS
- 2.93
- Period
- 2019
- Total Assets
- 939.16
- Total Liabilities
- 159.37
- Total Equity
- 779.79
- Tangible Book Valueper Share Common Eq
- 71.07
- Period
- 2019
- Cashfrom Operating Activities
- 43.4
- Cashfrom Investing Activities
- 1.39
- Cashfrom Financing Activities
- -51.25
- Net Changein Cash
- -6.45
- Period
- 2018
- Total Revenue
- 377.99
- Selling/ General/ Admin Expenses Total
- 82.48
- Depreciation/ Amortization
- 22.86
- Other Operating Expenses Total
- 122.3
- Total Operating Expense
- 320.63
- Operating Income
- 57.36
- Net Income Before Taxes
- 53.73
- Net Income
- 39.38
- Diluted Normalized EPS
- 3.7
- Period
- 2018
- Total Assets
- 961.42
- Total Liabilities
- 209.96
- Total Equity
- 751.46
- Tangible Book Valueper Share Common Eq
- 68.57
- Period
- 2018
- Cashfrom Operating Activities
- 14.3
- Cashfrom Investing Activities
- -236.51
- Cashfrom Financing Activities
- 222.22
- Net Changein Cash
- 0.01
- Period
- 2023-12-31
- Total Revenue
- 216.05
- Selling/ General/ Admin Expenses Total
- 37.76
- Depreciation/ Amortization
- 12.4
- Other Operating Expenses Total
- 18.94
- Total Operating Expense
- 186.12
- Operating Income
- 29.92
- Net Income Before Taxes
- 30.81
- Net Income
- 19.07
- Diluted Normalized EPS
- 1.78
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 237.98
- Selling/ General/ Admin Expenses Total
- 38.56
- Depreciation/ Amortization
- 12.3
- Other Operating Expenses Total
- 23.32
- Total Operating Expense
- 197.56
- Operating Income
- 40.42
- Net Income Before Taxes
- 42.63
- Net Income
- 27.58
- Diluted Normalized EPS
- 2.57
- Period
- 2023-09-30
- Total Assets
- 1315.65
- Total Liabilities
- 351.82
- Total Equity
- 963.83
- Tangible Book Valueper Share Common Eq
- 87.73
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 30.66
- Cashfrom Investing Activities
- 5.66
- Cashfrom Financing Activities
- -38.53
- Net Changein Cash
- -2.2
- Period
- 2023-06-30
- Total Revenue
- 235.48
- Selling/ General/ Admin Expenses Total
- 39.2
- Depreciation/ Amortization
- 11.94
- Other Operating Expenses Total
- 24.08
- Total Operating Expense
- 204.3
- Operating Income
- 31.19
- Net Income Before Taxes
- 32.97
- Net Income
- 20.83
- Diluted Normalized EPS
- 1.94
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 198.98
- Selling/ General/ Admin Expenses Total
- 41.68
- Depreciation/ Amortization
- 12.81
- Other Operating Expenses Total
- 25.08
- Total Operating Expense
- 186.14
- Operating Income
- 12.84
- Net Income Before Taxes
- 19.19
- Net Income
- 13.92
- Diluted Normalized EPS
- 1.3
- Period
- 2023-03-31
- Total Assets
- 1281.36
- Total Liabilities
- 353.68
- Total Equity
- 927.69
- Tangible Book Valueper Share Common Eq
- 84.44
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 67.79
- Cashfrom Investing Activities
- -61.08
- Cashfrom Financing Activities
- -50.02
- Net Changein Cash
- -43.31
- Period
- 2022-12-31
- Total Revenue
- 202.46
- Selling/ General/ Admin Expenses Total
- 36.62
- Depreciation/ Amortization
- 11.79
- Other Operating Expenses Total
- 22.82
- Total Operating Expense
- 180.3
- Operating Income
- 22.16
- Net Income Before Taxes
- 23.54
- Net Income
- 15.28
- Diluted Normalized EPS
- 1.41
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Shalby Technical
Moving Average
SMA
- 5 Day265.94
- 10 Day270.7
- 20 Day272.21
- 50 Day261.99
- 100 Day283.96
- 300 Day264.69
Shalby Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Kovai Medical Centre and Hospital
- 3930
- 135.4
- 3.57
- 4271.95
- 1923.27
- 4300.31
- Thyrocare Technologies
- 621
- -1.3
- -0.21
- 722
- 449.95
- 3286.96
- Shalby
- 269.1
- -0.85
- -0.31
- 333.85
- 134.8
- 2887.71
- Artemis Medicare Services
- 179
- -14.2
- -7.35
- 199
- 73.75
- 2400.73
- Indraprastha Medical Corp
- 240.4
- 0.5
- 0.21
- 282.45
- 80
- 2203.82
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Kovai Medical Centre and Hospital
- 36.69
- 5.95
- 18.22
- 11.04
- Thyrocare Technologies
- 50.3
- 6.1
- 23.49
- 21.55
- Shalby
- 42.31
- 3.09
- 5.41
- 7.74
- Artemis Medicare Services
- 68.76
- 6.23
- -
- -
- Indraprastha Medical Corp
- 25.98
- 5.94
- 15.48
- 5.19
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Feb-24
- Quarterly Results
- 27-Oct-23
- Quarterly Results
- 20-Jul-23
- Quarterly Results
- 18-May-23
- Audited Results & Final Dividend
- 15-May-23
- Audited Results & Final Dividend
- 17-Jan-23
- Quarterly Results
- 18-Oct-22
- Quarterly Results
- 26-Jul-22
- Quarterly Results
- 25-May-22
- Audited Results & Final Dividend
- 02-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 20-Aug-23
- 13-Jul-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 18-May-23
- -
- 08-Aug-23
- 1.2
- 25-May-22
- -
- 19-Sept-22
- 1
- 05-May-21
- -
- 17-Sept-21
- 1